Asana Recovery Responds to Increased Demand for Outpatient Addiction Treatment in Orange County
'Outpatient care allows us to meet clients where they are—offering effective treatment without interrupting their lives.'— Mark Shandrow, CEO of Asana Recovery
ORANGE COUNTY, CA, UNITED STATES, June 13, 2025 / EINPresswire.com / -- Addiction treatment providers in Orange County are observing a noticeable shift toward outpatient drug rehab programs as more individuals seek flexible recovery options that allow them to continue participating in their daily lives. In response, Asana Recovery, a behavioral health provider based in Costa Mesa, has expanded its outpatient services to meet this growing demand.
Asana Recovery now offers a range of outpatient programs designed to support individuals with substance use disorders and co-occurring mental health conditions. These services include standard outpatient treatment, an Intensive Outpatient Program (IOP), and access to virtual care, allowing for greater flexibility without compromising clinical effectiveness.
Outpatient Drug Rehab: A Growing Trend in Orange County
Outpatient rehab programs provide an alternative to inpatient treatment by enabling participants to receive structured care while continuing to live at home. This format allows clients to maintain work, school, and family obligations, which is increasingly important for adults balancing multiple responsibilities.
'Outpatient care is an important part of the recovery continuum,' said a spokesperson for Asana Recovery. 'It offers stability, accessibility, and the opportunity for clients to remain engaged in their everyday environment while receiving professional support.'
Many individuals in Orange County are choosing outpatient care due to its adaptability, lower cost compared to inpatient programs, and its capacity to preserve privacy and minimize disruption to daily routines.
Expanded Outpatient Services at Asana Recovery
Asana Recovery's outpatient programs are personalized based on each client's clinical and lifestyle needs. The multidisciplinary team provides:
• Individual Therapy: One-on-one sessions focused on identifying triggers, developing coping strategies, and addressing past trauma.
• Group Therapy: Facilitated peer groups that encourage accountability and shared learning experiences.
• Medication Management: Oversight for clients prescribed medications to support recovery or manage co-occurring conditions.
• Life Skills Support: Resources for managing stress, building healthy routines, and reintegrating into work or school environments.
For individuals requiring a higher level of care, Asana's Intensive Outpatient Program (IOP) offers structured programming several days per week. This option serves as a transitional step for those moving from detox or inpatient care and is also suitable for individuals who need enhanced support but cannot commit to residential treatment.
Integrating Mental Health and Addiction Treatment
Asana Recovery integrates dual diagnosis treatment into its outpatient programs, recognizing the link between substance use and mental health disorders such as anxiety, depression, and trauma. By addressing both simultaneously, the center aims to improve client outcomes and reduce the likelihood of relapse.
Improving Access to Care Through Insurance and Support
To ensure accessibility, Asana Recovery works with a broad range of insurance providers, including Aetna, Anthem Blue Cross, Blue Shield, Cigna, UMR, United Healthcare, and TriWest. Their team assists clients with verifying coverage and understanding financial options to help remove barriers to care.
Who Benefits from Outpatient Treatment?
Outpatient treatment is typically appropriate for individuals with mild to moderate substance use disorders, those transitioning from residential programs, or individuals with stable housing and support systems. Asana Recovery conducts thorough assessments to determine whether outpatient care is the right fit for each client.
Contact Information
For more information about outpatient addiction treatment in Orange County, visit Asana Recovery's website or contact the admissions team directly.
Asana Recovery
Phone: (949) 763-3440
Email: [email protected]
Website: https://asanarecovery.com
Mark Shandrow
Asana Recovery
+1 949-763-3440
email us here
Visit us on social media:
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
11 hours ago
- Yahoo
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Upturn
11 hours ago
- Business Upturn
QuasarMD Unveils Advanced Full-Body Light Therapy Mat to Support Aging Wellness
CHINO, Calif., July 29, 2025 (GLOBE NEWSWIRE) — QuasarMD LLC, a leader in light-based wellness technologies, announces the launch of its Full-Body Light Therapy Mat , a clinically validated, non-invasive solution designed to address the evolving wellness needs of aging adults. The full-body mat features 2,052 high-efficiency LEDs delivering dual-wavelength therapy: 660nm red light for surface-level benefits, and 850nm near-infrared (NIR) for deep penetration. Both wavelengths are clinically proven to provide cellular-level therapeutic effects. Specifically designed for aging users, the system provides gentle yet effective relief for common age-related concerns including joint stiffness, muscle fatigue, circulation challenges, and chronic conditions like arthritis or back and knee pain. Designed with Aging in Mind 'Chronic pain, sleepless nights, and reduced mobility are common challenges as we age,' said a spokesperson for QuasarMD. 'Our full-body light therapy mat was specifically developed to help older adults restore their vitality through scientifically validated, non-invasive technology that integrates effortlessly into daily life.' The QuasarMD Full-Body Light Therapy Mat is FDA-cleared device meeting professional-grade standards. Its home operation couldn't be simpler – just lie down and press a button. Featuring an innovative wrap-around design, the mat cossets the body in comfort to ensure complete light exposure from head to toe. Users can easily customize their therapy experience by adjusting time, intensity, and pulse settings for each session. It has a multi-layered fabric design with an inner layer of TPU that enhances light retention, improving both durability and light efficiency. Additionally, it is waterproof and easy to clean, making it convenient for daily use by seniors and caregivers alike. The QuasarMD mat is more than just a health tool – it's a companion for active aging, offering a drug-free, non-invasive way to manage pain, inflammation, and fatigue. Its gentle warmth and therapeutic light not only ease physical discomfort but also enhance mental well-being, improve blood circulation, promote deep relaxation, and foster an enduring sense of vitality – all essential components of healthy aging. 'Today's aging population is more proactive about wellness than ever,' noted the spokesperson. 'Caregivers, wellness professionals, and older adults increasingly demand safe, science-backed solutions that are both effective and convenient for home use. The evidence supporting red and NIR light therapy is robust – and truly empowering.' 'That's why we've developed this solution: to help people naturally manage discomfort, improve sleep quality, and support long-term vitality – all without medications or invasive treatments.' About the Company QuasarMD LLC is a California-based wellness technology company specializing in FDA-cleared light therapy devices that blend clinical efficacy with user-friendly design. Dedicated to working on well-being through the life stages, it has kept innovating non-invasive devices that assist in recovery, wellness, and vigor through light. The Full-Body Light Therapy Mat is now available for purchase at the official QuasarMD shop and through Amazon . Media Contact:QuasarMD LLC Email: [email protected] Phone: 917-426-2860 Address: 15515 Dupont Avenue, Chino, CA 91710, USA Website:
